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Background: Two important consequences of the normal ageing process are sarcopenia (the age-related loss of
muscle mass and function) and age-related cognitive decline. Existing data support positive relationships between
muscle function, cognition and brain structure. However, studies investigating these relationships at older ages are
lacking and rarely include a measure of muscle size. Here we test whether neck muscle size is positively associated
with cognition and brain structure in older men.
Methods: We studied 51 healthy older men with mean age 73.8 (sd 1.5) years. Neck muscle cross-sectional area
(CSA) was measured from T1-weighted MR-brain scans using a validated technique. We measured multiple
cognitive domains including verbal and visuospatial memory, executive functioning and estimated prior cognitive
ability. Whole brain, ventricular, hippocampal and cerebellar volumes were measured with MRI. General linear
models (ANCOVA) were performed.
Results: Larger neck muscle CSA was associated with less whole brain atrophy (t = 2.86, p = 0.01, partial eta squared
17%). Neck muscle CSA was not associated with other neuroimaging variables or current cognitive ability. Smaller neck
muscle CSA was unexpectedly associated with higher prior cognition (t = −2.12, p < 0.05, partial eta squared 10%).
Conclusions: In healthy older men, preservation of whole brain volume (i.e. less atrophy) is associated with larger
muscle size. Longitudinal ageing studies are now required to investigate these relationships further.
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As the population of the world ages, governments, re-
search funding bodies and the general public are becom-
ing increasingly interested in promoting healthy ageing.
Healthy ageing is not just the avoidance of pathology
but also the slowing down of the natural rate of ageing,
mainly through lifestyle adaptations. Two important
consequences of the normal ageing process are sarco-
penia and age-related cognitive decline (ARCD).
Sarcopenia is the loss of muscle mass and function
with advancing age [1-3]. It is a main component of the* Correspondence: a.kilgour@ed.ac.uk
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reproduction in any medium, provided the orfrailty syndrome, and greater degrees of sarcopenia are
associated with increased levels of falls, disability, mor-
bidity and death [4-6]. Muscle mass is lost from the third
decade at a rate of 1-2% per year, increasing with age
[7-9]. Muscle function deteriorates more quickly, with
studies showing strength to decline by 1-4% per year and
power to decline by 3-4% per year [8,10]. ARCD is the
normal and universal change in cognition seen with in-
creasing age [11]. Such changes mainly affect the so-called
‘fluid’ abilities (eg working memory, speed of processing,
reasoning). Crystallised abilities (eg. vocabulary, know-
ledge, autobiographical memory) remain largely intact
[12,13]. Studies have shown that the decline seen in fluid
cognitive abilities begins in early adulthood, with some de-
terioration seen by the early 20s [14].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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been studied in tandem; however, studies demonstrating
improved cognition in later life with increased physical
activity have highlighted this important area of research.
For example a Cochrane review of randomised controlled
trials found evidence that aerobic physical activities
improved cognitive function in healthy older adults, with
effects observed for motor function, cognitive speed, and
auditory and visual attention [15]. Observational studies
have also found positive relationships between physical
activity and cognitive function [16,17]. There is some
evidence that both grey and white matter brain volume
can be significantly improved by aerobic exercise in older
adults [18]. It was hypothesized that these relationships
were due solely to cardiovascular fitness, and although this
may play a role, animal studies have found other under-
lying mechanisms including: increased levels of brain-
derived neurotrophic factor which may contribute to
neurogenesis, effects on neurotransmitter systems and
increased insulin-like growth factor 1 [19].
Several studies have also demonstrated a positive rela-
tionship between muscle function (eg handgrip strength,
gait speed) and cognition [20-23]. Possible mechanisms
which might account for the shared variance in muscle
and brain size and function with healthy ageing include:
the role of hormones and growth factors (eg gluco-
corticoids) [24,25]; immunosenescence and inflamma-
tion (eg IL6 and CRP) [26,27]; oxidative stress and
mitochondrial ageing [28,29]; decreased stem cell activity
[30,31]; and environmental and lifestyle factors (eg
smoking) [32,33].
The above findings showing association between brain
and muscle structure and function add support to
the common cause hypothesis, that core underlying
processes determine the rate of ageing in each organ
throughout the body. If we are able to demonstrate an
association between muscle size and brain size and func-
tion, this could add further weight to the common cause
hypothesis [34-37]. This would have large implications
for future treatments designed to modify the rate of age-
ing, which could possibly target several organs at once
(eg muscle and brain) as opposed to individualised
treatments being developed.
It is known that muscle size and function (ie strength
or power) do not age in parallel [10,38], therefore the as-
sociation between muscle size and either brain structure
(eg whole brain volume) or cognitive function requires
independent study. We found only one study which has
investigated the relationship between muscle bulk and
brain structure in older adults; however, this study
included subjects with Alzheimer’s disease along with
normal controls [39]. The studies investigating muscle
size and cognition have largely relied on simple cognitive
screening tools (eg Mini Mental State Examination(MMSE)) and do not contain a measure or estimate of
prior cognitive ability [40-42].
Here we studied community-dwelling healthy older
men, measuring: neck muscle cross-sectional area (CSA),
multiple cognitive domains including estimated prior cog-
nitive ability and neuroimaging volumes. We hypothesised
that lower muscle bulk is associated with structural




Participants were 51 community-dwelling men involved
in a longitudinal ageing study investigating healthy age-
ing, glucocorticoid status and brain structure [43,44].
The study was approved by the Lothian Health Ethics
Committee. All subjects gave written informed consent
and the research was carried out in compliance with the
Helsinki Declaration. Data from the second wave of the
study were used because the smaller MR head coil used
in the first wave excluded the neck muscles. Exclusion
criteria were previously provided [43,44]. Participants
were healthy, lacking of significant illness, including
dementia, stroke, ischaemic heart disease, depressive illness,
excessive alcohol intake, and cancer. No participants were
taking psychotropic medication.
MR brain imaging
The full MR brain imaging protocol has been previously
published [43]. In summary, imaging was performed on
a GE Signa LX 1.5 T (General Electric) MR scanner.
Participants received a sagittal T1-weighted spin echo
sequence covering the whole head (TR 450 msec, TE
9 msec, FOV 24 cm, matrix 256 × 224, slice thickness
5 mm (no gap)) and a volume scan consisting of a
T1-weighted 3D inversion recovery prepared sequence
(3D IR_PREP) acquired in the coronal plane with slices
perpendicular to the long axis of the hippocampus and
covering the whole head (TI 600 msec with TE set to
minimum, FOV 22 cm, matrix 256 × 192, slice thickness
1.7 mm (no gap)).
Brain structure measurements
Image analysis was performed using Analyze v7.0 for
Windows (Mayo Clinic, Rochester, MA). Whole brain,
hippocampal and ventricular volumes [43], and intracra-
nial area (a validated estimate of intracranial volume
[45]) were obtained by an experienced rater.
Neck muscle cross-sectional area
We used neck muscle cross-sectional area (CSA) as a
measure of muscle size. We have previously shown in a
study of 24 subjects that neck muscle CSA is strongly
correlated with thigh muscle CSA (R2 0.77), which is
Table 1 Neuroimaging and muscle cross-sectional
area data
N Mean Std. Deviation
Whole brain volume (cm3) 50 1149.8 90.4
Intracranial area (cm2) 50 157.9 9.6
Total ventricular volume (cm3)* 50 31.2 24.0
Total hippocampal volume (cm3) 48 7.0 0.8
Cerebellar volume (cm3) 50 135.4 14.3
Total SCM muscle area (cm2) 49 5.1 1.1
Total comb muscle area (cm2) 49 22.8 3.1
Total muscle area (cm2) 49 28.0 3.4
Valid N (listwise) 47
*Non-parametric data, median and inter-quartile range presented.
Table 2 Prior and current cognition data
N Mean Std. Deviation
National adult reading test * 47 42.0 13.0
Mini mental state Examination * 50 28.0 4.0
Controlled word association test 47 40.4 10.9
Digit symbol substitution test 46 43.3 10.7
Raven’s standard progressive matrices 46 40.0 9.1
Logical memory 47 51.6 15.0
Visual reproduction 47 46.4 14.8
Auditory-verbal learning test 47 49.9 9.0
Benton visual retention test * 47 17.0 4.0
Factor 1 (Memory) 45 0.0 1.0
Factor 2 (Cognitive processing) 45 0.0 1.0
Valid N (listwise) 45
*Non-parametric data, median and inter-quartile range presented.
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muscle CSA is generally available in brain MRI studies,
whereas thigh muscle CSA is not usually measured within
longitudinal cognitive ageing studies. Neck muscle CSA
was measured using a validated technique [46]. Full details
can be obtained in the technique paper; however, in sum-
mary, the mid-point of the C2-vertebra was located in the
sagittal slice of a 3D reconstructed image. The image was
then converted to a transverse view and the posterior neck
muscles were outlined using a cursor. The software then
calculated the contained area. The muscles measured were
the semispinalis capitis, splenius capitis and trapezius
(measured as a combined group), and the sternoclei-
domastoid.
Tests of cognitive function
The following tests of cognitive function were performed
as part of the original study, as previously described
[43]: the Mini-Mental State Examination (MMSE, a
screening test for cognitive impairment); the Controlled
Word Association Test (CWAT, tests verbal fluency,
which is an aspect of executive function); the Digit-
Symbol Substitution Test (DSST, tests attention and
processing speed) from the Wechsler Adult Intelligence
Scale; Raven’s Standard Progressive Matrices (RSPM,
tests non-verbal reasoning, an important aspect of fluid
intelligence); Logical Memory (tests immediate and
delayed verbal declarative memory); Visual Reproduction
(tests immediate and delayed visual memory); Rey’s
Auditory-verbal Learning Test (tests verbal memory and
learning); Benton’s Visual Retention Test (tests visual
memory); and the National Adult Reading Test (NART,
provides an estimate of prior general cognitive ability).
Due to the strong correlation between pre-morbid cog-
nitive ability (of which NART provides an estimate) and
educational achievement [47], it was decided to include
only NART and not educational achievement as a pre-
dictor variable. One participant had a MMSE below 24
and was excluded from the analysis as this score may be
reflective of an incipient diagnosis of dementia.
Statistical analysis
Descriptive statistics, exploratory analyses, general linear
modeling (Analysis of Covariance; ANCOVA) and prin-
cipal components analysis were performed on SPSS ver-
sion 18.0 for Windows. Missing values were excluded
listwise. For the ANCOVA we constructed baseline
models with the measures of brain structure and cogni-
tive ability as dependent (i.e. outcome) variables and
neck muscle CSA as an independent variable, adjusting
for intracranial area (ICA) and age. ICA is thought not
to change after the onset of age-related neuronal loss,
particularly in men, therefore can be used as a marker of
peak brain size, thus allowing the outcome variable to bemore reflective of brain atrophy [48]. Also, without
adjusting for ICA it could be argued that those with big-
ger skulls require larger neck muscles for support or that
they are just larger in proportion; therefore, this adjust-
ment also controls for this. We also adjusted for NART
since this was found to correlate significantly with neck
muscle CSA, brain volumes and current cognition. Fur-
thermore, in the models with current cognitive ability as
an outcome variable, adjusting for the NART score
allows the model to reflect the degree of cognitive ageing
that has taken place.
Results
All participants (n = 51) were male with a mean age of
73.8 years (sd 1.5). Descriptive statistics for participant
neuroimaging and neck muscle cross-sectional area data
are in Table 1. Of the 51 MR brain scans reviewed, we
were unable to measure neck muscle CSA on one scan as
the scan did not extend far enough inferiorly to include
the neck muscles at the required level for measurement
Table 3 Spearman’s rho correlations between
neuroimaging, muscle and cognitive variables
(with p values)
Total neck muscle CSA NART
Age .21 -.03
(.15) (.82)
Whole brain volume .07 .49
(.62) (<0.001)
Intracranial area -.11 .56
(.44) (<0.001)
Total ventricular volume .13 .10
(.10) (.50)
Hippocampal volume -.07 .48
(.67) (<0.001)
Cerebellar volume .03 .46
(.83) (<0.001)
Memory factor -.28 .13
(.07) (.40)
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the hippocampal volume could not be measured.
Table 2 contains the descriptive statistics for the cog-
nitive test data. To reduce the risk of type 1 statistical
error by testing multiple associations, we performed
principal components analysis. The Kaiser-Meyer-Olkin
measure verified sampling adequacy. Two principal
components were extracted employing varimax rotation;
the first had an eigenvalue of 2.58, explaining 36.9% of
the variance and the second had an eigenvalue of 2.4,
explaining 34.3% of the variance. For comprehensibility,
we refer to these components as ‘factors’ as is general
usage. Together, the factors explain 71.2% of the vari-
ance in the cognitive test scores. The cognitive tests
which focused on memory (ie Logical Memory, VisualTable 4 ANCOVA for whole brain volume with total neck mus
as predictor variables
Source Degrees of freedom F
Corrected model 4 12.85
Intercept 1 1.06
Age (years) 1 0.79
Intracranial area (cm2) 1 13.13
NART (Score out of 50) 1 8.43
Total neck muscle CSA (cm2) 1 8.16
Corrected total 45
*Unstandardised B coefficients reflect change in whole brain volume in cm3.Reproduction, AVLT and BVRT) had high factor loadings
for Factor 1; therefore, we hereafter call this factor the
Memory Factor. Factor 2 had high factor loadings for the
three other tests: CWAT, DSST and RSPM and hereafter
is referred to as the Cognitive Processing Factor.
Initially bivariate statistics were performed (Spearman’s
rho) (Table 3). The only variable to significantly correlate
with total neck muscle CSA was NART (rho -.36,
p = .01). NART was also found to correlate strongly with
the following variables: intracranial area; unadjusted
whole brain, hippocampal, and cerebellar volumes; and
the cognitive processing factor.
ANCOVA was performed to check for shared variance
among neck muscle CSA and the neuroimaging measures,
the cognitive factors, and NART. Models were corrected
for age, intracranial area (ICA, to correct for head size)
and NART, except in the model for NART where only age
and ICA were adjusted for. Total neck muscle CSA was
found to predict 17% of the variance in whole brain vol-
ume (t = 2.86, p = 0.01) (Table 4). However, total neck
muscle CSA did not significantly predict the variance in
ventricular, hippocampal or cerebellar volumes (p > 0.05).
Neck muscle CSA did not significantly predict variance
in either the memory factor or the cognitive processing
factor (p > 0.05) (Tables 5 & 6). Using the NART score as
an outcome variable, we found that total neck muscle
CSA predicts 10% of the variance in the NART score
(t = −2.12, p < 0.05) after adjusting for ICA and age.Discussion
We found that in healthy elderly men, preservation of
whole brain volume was associated with larger total neck
muscle cross-sectional area. Therefore in an elderly co-
hort, those that have a smaller muscle bulk have under-
gone more brain atrophy. This finding supports the
common cause hypothesis, by demonstrating that the
rate of sarcopenia and ARCD may occur in parallel
within individuals, driven by core underlying biological
processes. However, we found no significant association
between total neck muscle CSA and ventricular volumecle area, intracranial area, age and prior cognition
Unstandardised B* t Sig. Partial Eta squared
<.01 .56
491.40 1.03 .31 .03
-5.64 -.89 .38 .02
0.04 3.62 <.01 .24
3.85 2.90 .01 .17
0.09 2.86 .01 .17
Table 5 ANCOVA for Memory factor with total neck muscle area, intracranial area, age and prior cognition as predictor
variables
Source Degrees of freedom F Unstandardised B* t Sig. Partial Eta squared
Corrected model 4 1.23 .31 .11
Intercept 1 1.39 8.91 1.18 .25 .03
Age (years) 1 1.30 -.12 -1.14 .26 .03
Intracranial area (cm2) 1 0.02 <-.01 -.15 .88 .00
NART (Score out of 50) 1 1.56 .03 1.25 .22 .04
Total neck muscle CSA (cm2) 1 0.28 <.01 -.53 .60 .01
Corrected total 43
*Unstandardised B coefficients reflect change in factor score for the Memory Factor.
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or cerebellar volumes.
We unexpectedly found that total neck muscle CSA
was significantly negatively associated with estimated
prior cognitive ability (NART) after adjustment for ICA
and age, but we found no significant association between
total neck muscle CSA and current cognitive abilities.
This suggests that those with lower prior cognitive abil-
ity may have larger muscles in old age. Muscle mass in
old age is determined by 2 factors. Firstly, peak muscle
bulk obtained in young adulthood, and secondly, rate of
muscle atrophy with ageing. Therefore we hypothesise
that those with lower cognitive abilities may have under-
taken more manual work [49,50] and therefore achieved
a greater peak muscle bulk and a larger muscle mass in
old age. We can find no plausible explanation as to why
a lower prior cognitive ability would favour a slower rate
of muscle atrophy. We unfortunately do not have
sufficiently detailed previous occupational history or
socio-economic class data for the participants to be able
to test this theory further at this point.
We found only one previous study which investigated
the relationship between muscle size and brain size, and
this study also found a positive relationship between
muscle bulk and whole brain volume. Burns et al. stud-
ied elderly people with early Alzheimer’s disease (AD)
(n = 70) or normal cognition (n = 70) and found that
whole brain volume, normalized for head size, wasTable 6 ANCOVA for General Processing Factor with total nec
as predictor variables
Source Degrees of freedom F
Corrected model 4 5.19
Intercept 1 0.23
Age (years) 1 1.60
Intracranial area (cm2) 1 0.15
NART (Score out of 50) 1 11.86
Total neck muscle CSA (cm2) 1 2.86
Corrected total 43
*Unstandardised B coefficients reflect change in factor score for the General Procespredictive of lean mass as measured by DEXA (Beta .20,
p < .001) in both groups [39]. White matter volume was
the primary driving factor for the relationship (Beta .19,
p < .001) while grey matter volume showed no associ-
ation with lean mass. This indicates that the cause of loss
of lean muscle mass in AD may be different to normal
ageing as it is primarily grey matter that is lost in AD.
In the above study Burns et al. also investigated the re-
lationship between MMSE and a measure of global cog-
nitive performance (a composite score made up of the
results of a battery of tests, including the DSST and
verbal fluency) with muscle mass [15]. They found a
significant positive association between both the global
cognitive performance score (Beta .12, p = .007) and
MMSE (Beta .11, p = .009) and muscle mass, controlling
for age and sex but not for prior cognition which we
have shown to correlate with both brain and muscle size
(Table 3). Our study was able to investigate the relation-
ship between cognitive decline, by adjusting for prior
cognition using the NART score, and current cognition,
whereas this study only looked at cross-sectional data
from current cognition. This may explain why they
found an association between current cognition and
muscle mass and we did not.
Several large studies have also investigated the links
between muscle size and cognition. In a large cross-
sectional study of community dwelling women aged 75
or over (n = 7105), Nourhashemi et al. found that lowk muscle area, intracranial area, age and prior cognition
Unstandardised B* t Sig. Partial Eta squared
<.01 .35
3.06 .48 .63 .01
-.11 -1.26 .21 .04
<.01 .39 .70 .00
.06 3.44 <.01 .23
<.01 1.69 .10 .07
sing Factor.
Kilgour et al. BMC Geriatrics 2013, 13:20 Page 6 of 7
http://www.biomedcentral.com/1471-2318/13/20cognitive function was associated with low fat free mass
[41]. However the cognitive test used was the Short
Portable Mental Status Questionnaire (SPMSQ), which
consists of only 10 questions and is mainly used as a
screening test for cognitive impairment.
Conversely, Wirth et al. studied 4095 consecutive geri-
atric hospital patients and found that fat-free mass was
not associated with cognitive dysfunction, measured
using MMSE, after adjusting for age, sex and Barthel
index [42]. Also, Auyeung et al. studied 2737 cognitively
normal older people and found that appendicular skel-
etal muscle mass (ASM) was significantly predictive of
MMSE 4 years later in men but not women [40]. How-
ever, after adjustment for age, years of education and
baseline MMSE score, the relationship in men was not
significant either.
Our study has the benefit of including tests of both
prior and current cognitive function. This allows us to
look at cognitive decline rather than purely at current
cognitive ability, and is the only study we could find that
specifically tested the relationship between prior cogni-
tion and muscle size. Also, the three large studies
mentioned above used cognitive tests which are prima-
rily designed to screen for cognitive impairment (ie
SPMSQ and MMSE) rather than to detect the subtleties
of change in cognition with age [40-42], for which our
cognitive tests were specifically chosen. Burns et al. used
more detailed cognitive tests; however the numbers
involved in their study are much smaller compared to
the other three studies. Our study is the first to measure
muscle cross-sectional area and cognition or brain size;
the above mentioned studies used either bioimpedence
analysis or DEXA as the measure of muscle bulk.
The main limitations of our study are the lack of lon-
gitudinal data and the small sample size. In ageing stud-
ies longitudinal data are crucial as it is the rate of loss of
muscle size or brain size that is of interest rather than
measurements at a cross-sectional time point. With
brain size we can partially correct for this using intracra-
nial area, but with muscle size we are unsure if someone
has lost 10% of their lean body mass in the previous
decade or 50%, as clearly the peak muscle bulk obtained
will affect the final outcome greatly. The study also
contained mainly white males and this will affect the
generalisability of our results.Conclusion
In healthy older men preservation of whole brain vol-
ume is associated with larger muscle size and larger
muscle size was associated with lower prior cognition,
but not current cognition. These results support previ-
ous work in this area which has also found associations
between brain and muscle variables in older adults.Longitudinal ageing studies are now required to investi-
gate these relationships further.
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